Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Core EBITDA

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 9.5238.6721.1913.7111.39

What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?

The latest EV/Core EBITDA ratio of NATCO PHARMA is 9.52 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar20239.52
Mar202238.67
Mar202121.19
Mar202013.71
Mar201911.39

How is EV/Core EBITDA of NATCO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2023 9.52
-75.38
Mar2022 38.67
82.49
Mar2021 21.19
54.56
Mar2020 13.71
20.37
Mar2019 11.39 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Core EBITDA ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,822.2 Cr 1% 0.5% 59.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

0.5%

59.4%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses